Eli Lilly and financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
$13.86B $14.65B $15.69B $18.63B $20.37B $21.84B $23.08B $24.29B $22.60B $23.11B $19.62B $19.96B $21.22B $19.97B $21.49B $22.32B $24.54B $28.32B $28.54B $34.12B $0.00M
GM % Gross Margin %
76.74% 76.28% 77.40% 77.20% 78.80% 80.55% 81.08% 79.13% 78.78% 78.76% 74.85% 74.76% 73.09% 77.73% 78.22% 78.85% 77.66% 75.38% 76.77% 79.25% 0.00%
OM Operating Margin
26.40% 24.91% 26.29% 25.78% 27.42% 29.17% 29.35% 26.01% 22.19% 24.00% 16.97% 18.00% 18.24% 23.51% 28.04% 26.88% 28.94% 29.21% 30.32% 31.61% 0.00%
EPS Earnings Per Share
$2.87 $3.18 $3.54 $4.02 $4.42 $4.74 $4.41 $3.39 $4.15 $2.78 $3.43 $3.52 $4.28 $5.55 $6.04 $7.93 $8.16 $7.94 $6.62 $0.00
Div. Dividends
$1.42 $1.52 $1.60 $1.70 $1.88 $1.96 $1.96 $1.96 $1.96 $1.96 $1.96 $2.00 $2.04 $2.08 $2.25 $2.58 $2.96 $3.40 $3.92 $4.48 $0.00
PR % Payout Ratio %
50.35% 52.96% 50.31% 48.02% 46.77% 44.34% 41.35% 44.44% 57.82% 47.23% 70.50% 58.31% 57.95% 48.60% 40.54% 42.72% 37.33% 41.67% 49.37% 67.67% 0
Sha. Shares
1083.73m 1091.94m 1090.14m 1091.67m 1094.31m 1,098m 1153.14m 1106.9m 1109.6m 1062.08m 1054.56m 1050.44m 1049.12m 1047.19m 1008.72m 960.13m 906.58m 906.59m 900.16m 899.31m 900.16m
OCF Operating Cash Flow
$2.87B $1.91B $3.98B $5.15B $7.30B $4.34B $6.86B $7.23B $5.30B $5.74B $4.46B $2.96B $4.85B $5.62B $5.52B $4.84B $6.50B $7.26B $7.08B $4.24B $0.00M
FCF Free Cash Flow
$971.40M $615.50M $2.90B $4.07B $6.35B $3.57B $6.16B $6.56B $4.40B $4.72B $3.20B $1.71B $3.81B $4.54B $4.31B $3.80B $5.11B $5.95B $5.23B $4.55B $0.00M
FCFS Free Cash Flow Per Share
$0.87 $0.57 $2.67 $3.63 $5.69 $3.17 $5.13 $4.97 $3.83 $4.29 $2.70 $1.65 $3.55 $3.28 $2.44 $3.74 $4.93 $5.94 $5.10 $-1.72 $0.00